Stock Scorecard
Stock Summary for Harrow Inc (HROW) - $38.82 as of 8/18/2025 10:38:36 AM EST
Total Score
7 out of 30
Safety Score
44 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HROW
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HROW
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HROW
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HROW
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for HROW (44 out of 100)
Stock Price Rating (Max of 10) | 8 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 10 |
Book Value (Max of 10) | 2 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 4 |
Trading Volume (Max of 10) | 8 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HROW
Financial Details for HROW
Company Overview |
|
---|---|
Ticker | HROW |
Company Name | Harrow Inc |
Country | USA |
Description | Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 38.82 |
Price 4 Years Ago | 8.64 |
Last Day Price Updated | 8/18/2025 10:38:36 AM EST |
Last Day Volume | 881,449 |
Average Daily Volume | 596,451 |
52-Week High | 59.23 |
52-Week Low | 20.85 |
Last Price to 52 Week Low | 86.19% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 43.35 |
Sector PE | 59.06 |
5-Year Average PE | -88.61 |
Free Cash Flow Ratio | 27.15 |
Industry Free Cash Flow Ratio | 15.81 |
Sector Free Cash Flow Ratio | 30.26 |
Current Ratio Most Recent Quarter | 0.62 |
Total Cash Per Share | 1.43 |
Book Value Per Share Most Recent Quarter | 1.35 |
Price to Book Ratio | 29.82 |
Industry Price to Book Ratio | 31.11 |
Sector Price to Book Ratio | 26.93 |
Price to Sales Ratio Twelve Trailing Months | 6.50 |
Industry Price to Sales Ratio Twelve Trailing Months | 34.46 |
Sector Price to Sales Ratio Twelve Trailing Months | 15.21 |
Analyst Buy Ratings | 7 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 37,002,100 |
Market Capitalization | 1,436,421,522 |
Institutional Ownership | 58.96% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -64.00% |
Annual Earnings Growth | 28.39% |
Reported EPS 12 Trailing Months | -0.28 |
Reported EPS Past Year | -0.14 |
Reported EPS Prior Year | -0.21 |
Net Income Twelve Trailing Months | -10,228,000 |
Net Income Past Year | -17,481,000 |
Net Income Prior Year | -24,411,000 |
Quarterly Revenue Growth YOY | 30.20% |
5-Year Revenue Growth | 31.29% |
Operating Margin Twelve Trailing Months | 17.90% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 52,963,000 |
Total Cash Past Year | 47,247,000 |
Total Cash Prior Year | 74,085,000 |
Net Cash Position Most Recent Quarter | 14,479,000 |
Net Cash Position Past Year | -172,292,000 |
Long Term Debt Past Year | 219,539,000 |
Long Term Debt Prior Year | 183,172,000 |
Total Debt Most Recent Quarter | 38,484,000 |
Equity to Debt Ratio Past Year | 0.24 |
Equity to Debt Ratio Most Recent Quarter | 0.56 |
Total Stockholder Equity Past Year | 69,652,000 |
Total Stockholder Equity Prior Year | 70,766,000 |
Total Stockholder Equity Most Recent Quarter | 49,654,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -34,382,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.93 |
Free Cash Flow Past Year | -60,876,000 |
Free Cash Flow Prior Year | -148,713,000 |
Options |
|
Put/Call Ratio | 0.19 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.68 |
MACD Signal | 0.55 |
20-Day Bollinger Lower Band | 20.55 |
20-Day Bollinger Middle Band | 29.78 |
20-Day Bollinger Upper Band | 39.02 |
Beta | 0.41 |
RSI | 62.73 |
50-Day SMA | 34.72 |
150-Day SMA | 22.43 |
200-Day SMA | 18.83 |
System |
|
Modified | 8/16/2025 1:43:16 AM EST |